| 55.24 Delayed Data As of Sep 20 |  +0.94 / +1.73%Today’s Change | 36.28 Today|||52-Week Range 75.42 | +42.55% Year-to-Date |
| Why Is Perrigo (PRGO) Up 6.1% Since Last Earnings Report? Sep 07 / Zacks.com - Paid Partner Content |
| Previous close | 54.30 |
| Today’s open | 54.58 |
| Day’s range | 54.50 - 56.10 |
| Volume | 3,001,173 |
| Average volume (3 months) | 1,257,462 |
| Market cap | $7.6B |
| Earnings growth (last year) | +13.17% |
| Earnings growth (this year) | -13.41% |
| Earnings growth (next 5 years) | +3.35% |
| Revenue growth (last year) | -4.31% |
| P/E ratio | 85.0 |
| Price/Sales | 1.13 |
| Price/Book | 1.34 |
| Today’s change | Today’s % change | |
|---|---|---|
| CTLTCatalent Inc | +0.96 | +1.90% |
| JAZZJazz Pharmaceuticals... | -0.04 | -0.03% |
| BHCValeant Pharmaceutic... | -0.29 | -1.25% |
| SAGESAGE Therapeutics In... | +1.73 | +1.06% |
| Next reporting date | November 7, 2019 |
| EPS forecast (this quarter) | $0.92 |
| Annual revenue (last year) | $4.7B |
| Annual profit (last year) | $131.0M |
| Net profit margin | 2.77% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Murray S. Kessler |
Executive VP- Global Operations and Supply Chain Ronald Janish |
Corporate headquarters Dublin, Dublin |
